Press "Enter" to skip to content

New patent for Sanofi Aventis drug JEVTANA KIT

0
Copyright © DrugPatentWatch. Originally published at New patent for Sanofi Aventis drug JEVTANA KIT

Annual Drug Patent Expirations for JEVTANA+KIT
Annual Drug Patent Expirations for JEVTANA+KIT

Jevtana Kit is a drug marketed by Sanofi Aventis Us and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.

Drug patent litigation for JEVTANA KIT.

This drug has forty-nine patent family members in thirty-two countries.

The generic ingredient in JEVTANA KIT is cabazitaxel. One supplier is listed for this compound. Additional details are available on the cabazitaxel profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Sanofi Aventis drug JEVTANA KIT
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    DrugPatentWatch - Make Better Decisions